Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
16,250.00Prev. Close
16,156.00Volume
0Total traded value
NAUpper Circuit
19,387.00Lower Circuit
12,925.00Fundamentals
| Market Cap | ₹20,712Cr |
| ROE | 13.30% |
| P/E Ratio(TTM) | 117.59 |
| EPS(TTM) | 137.29 |
| P/B Ratio | 13.59 |
| Dividend Yield | 0.07% |
| Industry P/E | 35.21 |
| Book Value | 1187.77 |
| Debt to Equity | 0.10 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Neuland Labs
Neuland Laboratories makes essential ingredients, known as APIs, for the global pharmaceutical and biotech industry, through its Generic Drugs and Custom Manufacturing divisions. The company's primary vision is to help create a healthier world by working with trusted partners and using sustainable, collaborative business practices. As a manufacturing and development partner, Neuland successfully supplies its products to customers in over 80 countries around the world.;
| Parent Organisation | Neuland Laboratories Limited |
| Managing Director | Mr. Davuluri Rao |
| NSE Symbol | NEULANDLAB |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 69.65 | ||
| Jubilant Pharmova | NA (0.00%) | 38.40 | ||
| Acutaas Chemicals | NA (0.00%) | 63.27 | ||
| Aarti Drugs | NA (0.00%) | 25.07 |